CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Les Laboratoires Servier SAS is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Les Laboratoires Servier SAS
50 rue Carnot
Phone: +33 155726000p:+33 155726000 Suresnes, 92284  France
This is a Subsidiary, click here for the Parent Company
Business Summary
Les Laboratoires Servier SAS is a France-based pharmaceutical company. The Company manufactures drugs for cardiovascular diseases, diabetes, endocrinology, oncology, rheumatology, venous diseases, ENT (ear, nose and throat), neurosciences and asthenia, under the brand names: Coversyl, Coveram, Procoralan, Muphoran, Protelos, Daflon 500, Locabiotal, Valdoxan, Stablon and Arcalion, among others. The Company operates five research and discovery centers in France, as well as another research center in Hungary and 19 international centers for therapeutic research (ICTRs). Les Laboratoires Servier SAS is also involved in research and development of drugs in collaboration with other research communities, such as French universities and institutes, including the INSERM and the CNRS. The Company is established in 140 countries across five continents.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20109/30/2010Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President JacquesServier
Director of Operations Jean-PhilippeSeta
Head of Research & Development EmmanuelCanet
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Biofarma SAS
Biogaran SAS
Servier Pharmaceuticals LLC
Symphogen A/S

General Information
Outstanding Shares: 1,192,788 (As of 9/30/2010)


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023